Literature DB >> 3322362

Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients.

S Looareesuwan1, A H Merry, R E Phillips, R Pleehachinda, Y Wattanagoon, M Ho, P Charoenlarp, D A Warrell, D J Weatherall.   

Abstract

Erythrocyte survival times were measured in healthy Thai controls and in patients following clearance of asexual P. falciparum or P. vivax parasitaemia. In five controls the mean cell life (MCL) of compatible donor erythrocytes was 89.6 d (mean range 73-101 d) compared with a mean MCL of 56.8 d (range 30-66 d) for autologous erythrocytes in 12 falciparum patients. In one of these patients the survival curve was biphasic with a rapid loss of some labelled cells. The survival of compatible donor erythrocytes was also studied in 10 patients and two types of survival curve could be distinguished. In five patients the cells had a mean MCL of 64.4 d (range 42-90 d). In the others survival curves were curvilinear, suggesting a complex mechanism of cell clearance or the presence of more than one cell population. There was initially a more rapid rate of destruction. In P. vivax malaria the MCL of autologous erythrocytes in seven patients was a mean of 67.2 d (range 34-74 d) and that of compatible donor cells in six patients was 66.8 d (range 54-76 d). In all except one of these patients both autologous and donor cell survival curves could be fitted to straight lines. No increase in cell-bound IgG or C3 was evident in 12 patients tested. The differences between the mean MCL in all the groups of patients and the controls were statistically significant at the 5% level. This indicates an increased rate of erythrocyte destruction following clearance of P. falciparum or P. vivax parasites which is not antibody or complement mediated. The mechanism is unknown, but appears to be extrinsic to the erythrocytes themselves and may result from nonspecific activation of the reticuloendothelial function associated with the parasitic infection.

Entities:  

Mesh:

Year:  1987        PMID: 3322362     DOI: 10.1111/j.1365-2141.1987.tb06171.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  32 in total

Review 1.  Malarial anemia and STAT6.

Authors:  Kathryn J H Robson; David J Weatherall
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941

2.  Factors contributing to anemia after uncomplicated falciparum malaria.

Authors:  R N Price; J A Simpson; F Nosten; C Luxemburger; L Hkirjaroen; F ter Kuile; T Chongsuphajaisiddhi; N J White
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

3.  Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes.

Authors:  Krystal J Evans; Diana S Hansen; Nico van Rooijen; Lynn A Buckingham; Louis Schofield
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

4.  The levels of CD16/Fc gamma receptor IIIA on CD14+ CD16+ monocytes are higher in children with severe Plasmodium falciparum anemia than in children with cerebral or uncomplicated malaria.

Authors:  Lilian A Ogonda; Alloys S S Orago; Michael F Otieno; Christine Adhiambo; Walter Otieno; José A Stoute
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

5.  Sequential Plasmodium chabaudi and Plasmodium berghei infections provide a novel model of severe malarial anemia.

Authors:  Juliana V Harris; Tiffany M Bohr; Catherine Stracener; Mary E Landmesser; Vladimir Torres; Amos Mbugua; Chantal Moratz; José A Stoute
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

6.  Erythrocyte sequestration and anemia in severe falciparum malaria. Analysis of acute changes in venous hematocrit using a simple mathematical model.

Authors:  T M Davis; S Krishna; S Looareesuwan; W Supanaranond; S Pukrittayakamee; K Attatamsoonthorn; N J White
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro.

Authors:  Guillaume Deplaine; Innocent Safeukui; Fakhri Jeddi; François Lacoste; Valentine Brousse; Sylvie Perrot; Sylvestre Biligui; Micheline Guillotte; Corinne Guitton; Safi Dokmak; Béatrice Aussilhou; Alain Sauvanet; Dominique Cazals Hatem; François Paye; Marc Thellier; Dominique Mazier; Geneviève Milon; Narla Mohandas; Odile Mercereau-Puijalon; Peter H David; Pierre A Buffet
Journal:  Blood       Date:  2010-12-16       Impact factor: 22.113

8.  Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria.

Authors:  J Riopel; M Tam; K Mohan; M W Marino; M M Stevenson
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumor necrosis factor alpha, and gamma interferon.

Authors:  G S Yap; M M Stevenson
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Vivax malaria: a major cause of morbidity in early infancy.

Authors:  Jeanne R Poespoprodjo; Wendelina Fobia; Enny Kenangalem; Daniel A Lampah; Afdal Hasanuddin; Noah Warikar; Paulus Sugiarto; Emiliana Tjitra; Nick M Anstey; Ric N Price
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.